1. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis
   Qingbao Li et al, 2016, Oncotarget CrossRef
2. Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations
   Ilenia Chatziandreou et al, 2015, PLOS ONE CrossRef
3. The Prognostic Value of SOX2 Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
   Yansu Chen et al, 2013, PLoS ONE CrossRef
4. Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer
   Johanna Samulin Erdem et al, 2016, BMC Cancer CrossRef
5. Functional characterization of SOX2 as an anticancer target
   Shizhen Zhang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
6. The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer
   Eva Sodja et al, 2016, Radiology and Oncology CrossRef
7. MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
   Kang Qin et al, 2023, Cancers CrossRef